AI assistant
ABBOTT LABORATORIES — Director's Dealing 2010
Sep 21, 2010
29777_dirs_2010-09-21_de07c0b2-bd5c-4ad3-98fd-b660a897fbb7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2010-09-17
Reporting Person: Forrest A. David (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-09-17 | Common shares without par value | A | 21000 | — | Acquired | 34204 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-09-17 | Option (right to buy) | $51.74 | A | 14350 | Acquired | 2020-09-16 | Common shares (14350) | Direct |
Footnotes
F1: These shares represent a retention award of restricted stock under the Abbott Laboratories 2009 Incentive Stock Program. These awards generally vest on the third anniversary of their grant date and include the right to have stock withheld for tax purposes.
F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 4,784 on 09/17/2011, 4,783 on 09/17/2012, and 4,783 on 09/17/2013.